Met Life Investment Management, LLC Nex Immune, Inc. Transaction History

Met Life Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.11 - $15.13 $31,663 - $116,561	-7,704 Closed	0 $0
Q3 2021 May 17, 2024	BUY	$10.32 - $16.9 $79,505 - $130,197	7,704 New	7,704 $116,000
Q3 2021 Jun 21, 2023	BUY	$10.32 - $16.9 $79,505 - $130,197	7,704 New	7,704 $116,000
Q3 2021 Mar 22, 2023	BUY	$10.32 - $16.9 $79,505 - $130,197	7,704 New	7,704 $116,000
Q3 2021 Nov 15, 2021	BUY	$10.32 - $16.9 $79,505 - $130,197	7,704 New	7,704 $117,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $6.04M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.